Corona Testing Miami

COVID-19 testing now

HOME
SERVICES
ANTIBODY TREATMENT
ABOUT
CONTACT
New Patient/CC Form
Free Testing Sites
More

Use tab to navigate through the menu items.

Acerca de

WE'RE HERE TO HELP GET YOU BACK OUT THERE

WHAT IS Bebtelovimab?

Bebtelovimab consist of two monoclonal antibodies that bind to the spike protein and prevent the COVID19 virus from spreading and fight off any active infection. Spike proteins are what the virus uses to enter a cell.

WHAT ARE MONOCLONAL ANTIBODIES

- Single antibody that replicate to fight active disease and infection such as COVID19.

- Created in lab settings that are derived from actual antibodies found in white blood cells, being created in lab eliminates any bacteria through blood.

Marathon Runners

Benefits

- 99% of virus reduction within days
- Prevents hospitalization by over 80%
- Prevents the virus from spreading which will diminish virus rapidly.
- Provides strong antibody protection
- Rapidly Increases your body antibody immune response.

How We Work

- All treatments are provided to you at the comfortability and privacy at your home.
- All staff are registered nurses that are of golden standard
- Once nurse arrives we will take patient vitals (blood pressure, oxy, heart rate.)
- Administer Sotrovimab over a 30 min period in a 100 ML sodium solution
- Once treatment is complete re check vitals, and monitor for 45 min.

Waivers and Liability

- All patients will sign and review facts sheet provided from Bebtelovimab
- All clients will review and sign waiver provided from Regen-X
- All clients will fill out a short intake form

Monoclonal Antibody Concierge Home Infusion Registration

To register for your service, please take the time to fill out the information below.

First Name

Phone

Last Name

Birthday

Select an Address

Gender

Relevant Medical History

Asthma

Diabetes

Heart Disease

COPD

Respitory Disease

Weakened Immune System

BMI of above 35

Chronic Kidney Disease

Email

I agree to the terms & conditions I agree to terms & conditions. Bebtelovimab Treatment in cases of COVID-19: I hereby certify that I have been given the opportunity to discuss the risks, benefits, alternatives, and possible modes of treatment. We have jointly arrived at the decision to proceed with the administration of Bebtelovimab, which are currently authorized for emergency use by the Food & Drug Administration (FDA). I, the undersigned, hereby authorize Regenx MD and/or their designee to administer and/or dispense Bamlanivib, a monoclonal antibody for the purpose of treating COVID-19, and to perform such additional procedures as are considered necessary to monitor and care for this patient while participating in this treatment course. • B have not been approved, but have been authorized for emergency use by FDA, to treat mild to moderate COVID19 in adults and pediatric patients with positive results of direct SARS-CoV-2 viral testing who are 12 years of age and older weighing at least 40 kg, and who are at high risk for progressing to severe COVID-19 and/or hospitalization. • Bebtelovimab are authorized only for the duration of the declaration that circumstances exist justifying the authorization of the emergency use under Section 564(b)(1) of the Act, 21 U.S.C. 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner. Some of the known risks of these medications explained to me include, but are not limited to allergic reactions, fever, chills, nausea, headache, shortness of breath, low blood pressure, wheezing, swelling of my lips, face, or throat, rash, including hives, itching, muscle aches and dizziness. These can happen during and after the infusion and should be reported to my healthcare provider right away. These are not all the possible side effects. Serious and unexpected side effects may happen. Bebtelovimab is still under investigation. Therefore, there may be risks, side effects, and/or longterm effects that are related to this treatment but are unknown at this time. I have been advised of risks and possible benefits, although no guarantee or assurance has been made as to the results to be obtained. This treatment has been explained to me. Additional printed material specific to my drug therapy has been reviewed and given to me. I received and reviewed the Fact Sheet for Patients, Parents and Caregivers Emergency Use Authorization (EUA) of Bebtelovimab for Coronavirus Disease 2019 (COVID-19). This permission is based on knowledge and understanding of the elements of the therapy and an awareness of the risks, consequences, and discomforts. I will self-isolate and use infection control measures (e.g. wear mask, isolate, social distance, avoid sharing personal items, clean and disinfect “high touch” surfaces, and perform frequent hand washing) according to CDC guidelines. I understand clearly that I can stop my participation in treatment at any time and that such a discontinuation will not prejudice my future medical care. I, the undersigned, hereby consent to proceed with the use of this medication. Regenx MD does not charge for the monoclonal antibodies. RegenX MD Charge is for the home concierge service. We do not accept Medicaid, Medicare or insurance for this fee.

I agree to the terms & conditions, RegenX MD does not accept Medicare or Medicaid. The home service is a private pay service and I agree that I will not be submitting any claims to Medicare or Medicaid for reimbursement

Have You Been Vaccinated

Are You Around A High Exposure Environment to COVID 19

Site by www.DiGiSolAgency.com